Latest Breaking News On - Senior research biotechnology analyst - Page 1 : comparemela.com

NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia - NLS Pharmaceutics (NASDAQ:NLSPW), NLS Pharmaceutics (NASDAQ:NLSP)

ZURICH, SWITZERLAND / ACCESSWIRE / November 27, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW)) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery

Marianne lambertsonMichael thorpyFrancois briseboisEdward mezerhaneAlex zwyerCentessa pharmaceuticalsPharmaceutics ltdAvadel pharmaceuticalsSenior research biotechnology analystChief executive officerOppenheimer sleep disorders summitDeep diveIdiopathic hypersomniaManaging directorNew yorkKey opinion leaders

NLS Pharmaceutics AG: NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia

NLS Pharmaceutics AG: NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Marianne lambertsonFrancois briseboisMichael thorpyStefan klotterAlex zwyerEdward mezerhaneSenior research biotechnology analystCentessa pharmaceuticalsPharmaceutics ltdAvadel pharmaceuticalsPharmaceutics ltd viewChief executive officerOppenheimer sleep disorders summitDeep diveIdiopathic hypersomniaManaging director